Study Stopped
the clinical data collected to date are sufficient for regulatory requirements
Observational Study to Evaluate Clinical Performance and Safety in Total Knee Arthroplasty
1 other identifier
observational
163
1 country
3
Brief Summary
The aim of this study is to assess the long-term performance and safety of HLS KneeTec cementless and hybrid fixation knee prosthesis when used in standard medical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2020
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2020
CompletedFirst Submitted
Initial submission to the registry
April 26, 2021
CompletedFirst Posted
Study publicly available on registry
May 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2024
CompletedFebruary 6, 2025
February 1, 2025
4.4 years
April 26, 2021
February 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of implant survival in subjects receiving a total knee arthroplasty with the HLS KneeTec cementless and hybrid fixations up to 10 years after the surgery
Kaplan Meier survival rate up to 10 years after the surgery.
10-year
Secondary Outcomes (4)
Evaluation of clinical performance of the HLS KneeTec cementless and hybrid fixations after the surgery
starting preoperatively up to 10 years
Evaluation of clinical performance of the HLS KneeTec cementless and hybrid fixations after the surgery
5 and 10 years
Radiographic analysis of the HLS KneeTec cementless and hybrid fixations at 4 months, 1, 5 and 10 years minimum
4 months, 1, 5 and 10 years
Evaluation of safety performance during the surgery up to 10 years after the surgery
starting intraoperatively up to 10-year FU
Interventions
patient with HLS KneeTec cementless and hybrid fixation prosthesis
Eligibility Criteria
All patients treated with HLS KneeTec (cementless or hybrid versions) implant will be included. All eligible patients seen in consultation and who agree to participate in the study should be included, systematically and consecutively, since the initiation of the study
You may qualify if:
- Male or female aged 18 - 80 years old at the time of the surgery
- Implanted (or with an indication) with an HLS KneeTec Cementless or hybrid fixation according to the Instructions for Use (IFU)
- Patients agree to consent to collect data from their medical records and agree to answer questionnaires for the purposes of the study.
You may not qualify if:
- \- Patients under guardianship and/or those who, according to the investigator or his delegated research team, will not be able to comply with the study procedures. (e.g. illiteracy, recent psychotic or manic disorders and/or inability to comply with routine follow-up visits.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Corinlead
Study Sites (3)
Chu Angers
Angers, 49933, France
Clinique Du Parc
Caen, 14000, France
Centre Hospitalier Compiegne Noyon
Compiègne, 60200, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Franck MABESOONE, MD
CH COMPIEGNE
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2021
First Posted
May 5, 2021
Study Start
July 17, 2020
Primary Completion
December 19, 2024
Study Completion
December 19, 2024
Last Updated
February 6, 2025
Record last verified: 2025-02